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Paraganglioma – a cause of hypertension in a young patient
Paragangliom kao uzrok hipertenzije kod mladog bolesnika
Nataša Rakonjac, Slobodan Markoviü
Clinical Hospital Centre Zemun, Belgrade, Serbia
Abstract
Introduction. Collections of neuroendocrine cells dispersed
throughout the body are known as paraganglia and the tumor
arising from these paraganglia are known as paragangliomas.
Paragangliomas located along side the aorta are associated
with the pheochromocytoma and they secrete and store cate-
cholamines. Case report. We reported a 29-year-old woman
with episodes of headache, palpitations, dizziness and sweats,
associated with hypertension. Elevated urine catecholamines
were consistent with pheochromocytoma. Nuclear magnetic
resonance (NMR) was performed and the symptoms were
caused by associated mediastinal and retroperitoneal paragan-
gliomas. The tumors were surgically removed. In a 3-year
follow-up period the patient had two recidivate lesions, one
of them was surgically removed, and for the last one a 6-
month follow-up was recommended, because urine
cathecholamine level was not significantly elevated and blood
pressure was normal. Conclusion. Clinical and imaging data
of patients with extra adrenal paragangliomas are not specific.
Many of them may be asymptomatic even when the lesion is
large, but if tumor is functional, diagnosis may be easier. Pa-
tients should be initially evaluated by determining catechola-
mine level, followed by computerized tomography (CT) or
NMR to locate the primary lesion. Since there are no definite
microscopic criteria for the distinction between benign and
malignant tumors, radical excision and prolonged follow-up is
necessary.
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Apstrakt
Uvod. Grupe neuroendokrinih ýelija koje su lokalizovane u
razliÿitim delovima tela poznate su kao paraganglije, a tumori
poreklom od ovih ýelija su paragangliomi. Paragangliomi lo-
kalizovani duž aorte imaju iste karakteristike kao feohromo-
citom, tj. luÿe poveýane koliÿine kateholamina. Prikaz bole-
snika. Prikazana je 29-godišna bolesnica sa povremenim gla-
voboljama, palpitacijama, muÿninama i preznojavanjem pra-
ýeni hipertenzijom. Poveýan nivo kateholamina u 24-
ÿasovnom urinu ukazivao je na postojanje feohromocitoma.
UraĀena je nuklearna magnetna rezonanca (NMR) toraksa i
abdomena i utvrĀeno je da su opisani simptomi uzrokovani
paragangliomima u posteriornom medijastinumu i retroperi-
toneumu. Tumorske mase bile su operativno odstranjene.
Tokom 3-godišnjeg praýenja, bolesnica je imala dva recidiva,
a jedan od njih je hirurski otklonjen. Posle otkrivenog drugog
recidiva, krvni pritisak i nivo kateholamina u 24-ÿasovnom
urinu bili su u granicama normale, te smo savetovali 6-
meseÿne redovne kontrole. Zakljuÿak. Kliniÿki i radiološki
znaci ekstraadrenalnih paraganglioma su nespecifiÿni. Mnogi
su asimptomatiÿni, ÿak i kada se radi o vrlo velikim lezijama,
ali ako su funkcionalne, dijagnoza je lakša. Kod takvih boles-
nika odreĀuje se nivo kateholamina u urinu i radi se kompju-
terizovana tomografija (KT) ili NMR radi lociranja primarne
lezije. Kako ne postoji definitivan mikroskopski kriterijum za
razdvajanje benignih od maligne lezije, neophodni su radikal-
na ekscizija i kliniÿko praýenje operisanih bolesnika.
Kljuÿne reÿi:
paragangliom; hipertenzija; hirurgija, operativne
procedure; dijagnostiÿke tehnike i procedure;
histologija.
Introduction
Collections of neuroendocrine cells dispersed through-
out the body are known as paraganglia and tumors arising
from these paraganglia are known as paragangliomas 
1. The
paraganglia based on their anatomic distribution can be di-
vided into three groups: branchiomeric, intravagal and aorti-
cosympathetic 
2. The branchiomeric and intravagal paragan-
glia are associated with the parasympathetic nervous system
and are located close to the major arteries and cranial nerves
of the head and neck.
Aorticosympathetic paragangliomas or extra-adrenal
pheochromocytomas are located along side of the aorta and are
associated with the sympathetic nervous system. They secrete
and store catecholamines. Symptoms such as hypertension,
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or palpitations are symptoms reported in patients with in-
creased catecholamine secretion in functional tumors 
3.
Computerized tomography (CT) scans or magnetic
resonance imaging (MRI) are very useful, but diagnoses of
paragangliomas can only be made with careful histological
and immunohistochemical evaluation 
4. Histologically, it is
well circumscribed neoplasm composed of epithelioid cells
with eosinophilic cytoplasm arranged in a group and periph-
erally surrounded by more spindle shaped cells. Immuno-
histochemical stains on the paraffin tissue specimen, includ-
ing chromogranin, synaptophysin, and S100, confirm the
neuroendocrine origin of this neoplasm.
The treatment of choice for paragangliomas is a com-
plete surgical resection followed by a prolonged follow-up.
This may be done by 6-month ultrasound and one-year CT or
MRI examinations 
5.
Case report
We described a 29-year-old woman presented with a 5-
month history of headache, palpitations, dizziness, sweats,
associated with hypertension (160/120 mm Hg), before any
examinations.
Routine laboratory tests recommended before initiating
therapy, which included urinalysis, blood glucose, hematocrit,
creatinine, calcium and lipoprotein profile, were normal. Hol-
ter electrocardiographic monitoring revealed inverted T wave
in D1, aVL, V4-V6 leads, which attended hypertension period.
Heart, thyroid and abdominal ultrasound, renal artery
doppler and ophthalmology examination were made to ex-
clude coarctation of the aorta, thyroid and parathyroid dis-
ease, renovascular hypertension, and the above tests were
normal.
Pheochromocytoma should be suspected in patients
with paroxysms of hypertension accompanied by headache,
palpitations, pallor perspiration and 24-hour urinary meta-
nephrine and normetanephrine is screening diagnostic test
for this disease. This involves obtaining a special urine con-
tainer, which has a small amount of preservative from a
medical laboratory and filling it with one entire day's worth
of urine. The test is somewhat inconvenient but well worth
the trouble due to its reliability and unrivaled specificity.
Twenty-four-hour urine collections in our patient
showed marked elevation of norepinephrine, light elevation
of epinephrine and normal level of dopamine.
The first thoracic and abdominal MRI scan demon-
strated a 30.7 u 23.6 u 15 mm mass in the right paravertebral
region in the level of costotransversal articulation of Th10,
with heterogeneous increased intensity on T2 weighted im-
ages, which suggested necrosis and cystic degeneration of le-
sion. The second lesion was 18 u 12.8 mm, with homogene-
ous high intensivity on T2 weighted images behind the right
renal vein and laterally from the inferior vena cava (Figures
1 and 2).
Fig. 2 – Toracoabdominal magnetic resonance (MR) scan
demonstrated paravertebral paragangliomas
Elevated urinary catecholamines and MRI scan were
consistent with an aorticosympathetic paraganglia in the
right paravertebral space.
Preoperative management – all patients with pheo-
chromocytoma and paraganglioma undergoing surgery
should receive preoperative medical management to mini-
mize operative and postoperative complications. The main
goal of preoperative management is to normalize blood pres-
sure, heart rate and protect a patient from the effects of high
levels of circulating catecholamines during surgery, which
may cause hypertensive crises and arrhythmias. Preoperative
management in this case included Į-adrenergic antagonists,
ȕ-adrenergic antagonists, calcium channel blockers and cate-
cholamine synthesis inhibitors.
Fig. 1 – Thoracic magnetic resonance image (MRI) demonstrated lesion in the right paravertebral region in the level of Th
10 vertebra. Abdominal MRI demonstrated lesion behind the right renal vein, laterally from the v. cava inferiorVolumen 69, Broj 8 VOJNOSANITETSKI PREGLED Strana 723
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The thoracic lesion was surgically removed without
complications, and four months later an abdominal mass was
removed, too. The characteristic of tumors were the same,
they were incapsulated, without capsular invasion, solid
formed, with abundant vascularisations, composed of epithe-
lioid cells, with eosinophilic cytoplasm, surrounded with
stromal septa. Immunohistochemistry showed strong positive
staining of vimentin, S-100 protein, chromogranin, synapto-
physin, thus the diagnosis of paraganglioma was confirmed
(Figures 3 and 4).
Fig. 3 – A patohistologic finding demonstrated epithelioid
cells, with eosinophilic cytoplasm, surrounded with stromal
septa (HE u45)
Fig. 4 – Immunohistochemistry – the presence of peripheral
S100-positive cells, typical for paragangliomas (S100 u65)
In one-year follow-up period, hypertension was persis-
tent and in 24-hour urine collections catecholamines level
was higher than normal. Functional imaging with metaiodo-
benzylguanidine was done and the result was normal, focal
lesion was not reviewed.
It has been proposed that all patients diagnosed with a
pheochromocytoma or paraganglioma should consider ge-
netic testing to early identificate a hereditary syndrome and
early screening for other associated tumors and eventual
identification of family members who are at risk. Many cases
of familial paraganglioma are caused by mutations in the
succinate dehydrogenase (succinate: ubiquinone oxi-
doreductase) subunit gene SDHD.
Genetic testing showed that the patient was negative for
a succinate dehydrogenase (SDH) subunit B mutation.
Multislice abdominal CT scan demonstrated inhomoge-
neously enhancing a soft-tissue mass of 20.8 mm located in
the right paravertebral area, in front of the anterior crus of
adrenal gland, behind the inferior vena cava (Figure 5). After
the third surgical intervention, histopatological characteris-
tics of the tumour indicated paragangliomas. Postoperatively,
the patient was normotensive and exhibited catecholamine
levels within the normal range.
Fig. 5 – Multislice computed tomography (CT)
demonstrated a soft-tissue mass a 20.8 mm located in the
right paravertebral area
Follow-up in six months was recommended. After 18
months MRI scan demonstrated 16 u 15 mm recidivate tu-
mour in the right retroperitoneal area in front of the anterior
crus of the adrenal gland, behind surgical clips. Abdominal
ultrasound demonstrated 14 mm hypoechoic lesion in the po-
sition of the right adrenal gland (Figure 6). However, cate-
cholamine level was not significantly increased and blood
pressure was normal.
Fig. 6 – Ultrasound showed a hypoehoic mass in the positin
of the right adrenal gland
Ultrasound and catecholamine level in 6 mounths and
CT scans or NMR per year were recommended.
Discussion
Paragangliomas are extra-adrenal pheochromocytomas
that arise from chromaffin cells in the sympathetic (localized
in the retroperitoneum and the thorax) or parasympathetic
(next to the aortic arch, neck, and skull base) neural paragan-
glial. They account for 10% of adult pheochromocytomas 
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About 70% of sympathetic paragangliomas are intraabdomi-
nal, usually found in the perinephric and paraaortic spaces.
The remaining 30% are located in the chest 
5. Associated to-
racal and abdominal paragangliomas, such as in the pre-
sented case, are very rare.
Extraadrenal paragangliomas affect patients in the 2nd
or 3rd decade of life 
6. It has been reported that 10%–40% of
extra-adrenal paragangliomas are malignant 
7. Distant me-
tastasis is the only reliable criteria for confirming malig-
nancy. Local tissue invasion or pathological evidence of nu-
clear pleomorphism or mitotic activity do not necessarily
imply malignancy 
8.
Functioning extra-adrenal paragangliomas represent
more than 10% of all pheochromocytomas 
9. Functional
paragangliomas secrete norepinephrine and normetanephrine
and account for 30–60% of tumors 
10. If secretory tumor is
present, patients undergo paroxysmal episodic hypertension,
as well as the typical triad of symptoms associated with
pheochromocytomas: palpitations, headache and profuse
sweating. The nonsecretory type most commonly presents as
abdominal pain or mass 
11 and a large proportion of these
tumors are incidentally discovered in normotensive patients
during imaging evaluation for other reasons 
12.
The diagnosis is usually established with high urine
catecholamine metabolites, VMA and metanephrine levels 
11.
The imaging modality of choice for primary tumor evalua-
tion and staging is CT of the thorax, abdomen and pelvis.
On CT, retroperitoneal paraganglioma appears as a hy-
pervascular mass. Areas of intralesional hemorrhage and necro-
sis can be frequently seen as the tumor enlarges. They are
commonly located in the para-aortic region, and they may be
confused with other retroperitoneal tumors, especially pancre-
atic tumors 
13. MRI is more sensitive than CT in detecting ex-
tra-adrenal tumors. Scintigraphy with 123-I labelled MIBG of-
fers superior specificity than CT and MRI imaging 
14. Genetic
disorders involving mutations within the succinate dehydroge-
nase B and D units (SDHB, SDHD) and the von Hippel-Lindau
(VHL) gene places an increased risk in the development of ex-
tra-adrenal paragangliomas and adrenal pheochromocytomas 
15.
The differential diagnosis of spinal paraganglioma in-
cludes metastases, multiple myeloma and other highly vascu-
lar tumors. Differentiation of paragangliomas from these tu-
mors is frequently not possible on MRI and CT, because of
considerable overlap in their imaging findings 
1. Thus, histo-
pathological findings are the only adequate diagnosis for para-
gangliomas.
Surgical excision remains the mainstay of treatment.
Since there are no definite microscopic criteria for the distinc-
tion between benign and malignant tumors, radical excision is
the treatment of choice and prolonged follow-up is necessary.
Conclusion
Clinical and imaging data of patients with extra adrenal
paragangliomas are not specific. Many of them may be
asymptomatic even when the lesion is large, but if tumor is
functional, diagnosis may be easier. Patients should be ini-
tially evaluated by determining catecholamine level, fol-
lowed by CT or MRI to locate the primary lesion. Since there
are no definite microscopic criteria for the distinction be-
tween benign and malignant tumors, radical excision and
prolonged follow-up is necessary.
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